Logo image of XP

XP INC - CLASS A (XP) Stock Fundamental Analysis

NASDAQ:XP - KYG982391099 - Common Stock

17.81 USD
-0.07 (-0.39%)
Last: 9/3/2025, 8:00:02 PM
17.85 USD
+0.04 (+0.22%)
Pre-Market: 9/4/2025, 9:04:54 AM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to XP. XP was compared to 239 industry peers in the Capital Markets industry. XP has a medium profitability rating, but doesn't score so well on its financial health evaluation. XP is growing strongly while it also seems undervalued. This is an interesting combination


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

XP had positive earnings in the past year.
In the past year XP had a positive cash flow from operations.
XP had positive earnings in each of the past 5 years.
Of the past 5 years XP 4 years had a positive operating cash flow.
XP Yearly Net Income VS EBIT VS OCF VS FCFXP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

1.2 Ratios

XP's Return On Assets of 1.32% is on the low side compared to the rest of the industry. XP is outperformed by 62.34% of its industry peers.
XP has a Return On Equity of 22.10%. This is amongst the best in the industry. XP outperforms 89.12% of its industry peers.
With a Return On Invested Capital value of 1.25%, XP is not doing good in the industry: 68.20% of the companies in the same industry are doing better.
XP had an Average Return On Invested Capital over the past 3 years of 1.49%. This is significantly below the industry average of 7.59%.
Industry RankSector Rank
ROA 1.32%
ROE 22.1%
ROIC 1.25%
ROA(3y)1.58%
ROA(5y)1.89%
ROE(3y)21.19%
ROE(5y)21.51%
ROIC(3y)1.49%
ROIC(5y)1.78%
XP Yearly ROA, ROE, ROICXP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

The Profit Margin of XP (28.02%) is better than 72.38% of its industry peers.
In the last couple of years the Profit Margin of XP has grown nicely.
XP has a Operating Margin of 33.11%. This is comparable to the rest of the industry: XP outperforms 58.16% of its industry peers.
XP's Operating Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 33.11%
PM (TTM) 28.02%
GM N/A
OM growth 3Y0.94%
OM growth 5Y1.22%
PM growth 3Y-3.75%
PM growth 5Y4.69%
GM growth 3YN/A
GM growth 5YN/A
XP Yearly Profit, Operating, Gross MarginsXP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1

2. Health

2.1 Basic Checks

XP has less shares outstanding than it did 1 year ago.
The number of shares outstanding for XP has been reduced compared to 5 years ago.
XP has a worse debt/assets ratio than last year.
XP Yearly Shares OutstandingXP Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
XP Yearly Total Debt VS Total AssetsXP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 100B 200B 300B

2.2 Solvency

XP has an Altman-Z score of 0.04. This is a bad value and indicates that XP is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.04, XP is not doing good in the industry: 74.06% of the companies in the same industry are doing better.
The Debt to FCF ratio of XP is 9.13, which is on the high side as it means it would take XP, 9.13 years of fcf income to pay off all of its debts.
XP's Debt to FCF ratio of 9.13 is in line compared to the rest of the industry. XP outperforms 56.07% of its industry peers.
XP has a Debt/Equity ratio of 4.06. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 4.06, XP is not doing good in the industry: 83.68% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 4.06
Debt/FCF 9.13
Altman-Z 0.04
ROIC/WACCN/A
WACCN/A
XP Yearly LT Debt VS Equity VS FCFXP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B 20B

2.3 Liquidity

A Current Ratio of 0.20 indicates that XP may have some problems paying its short term obligations.
XP's Current ratio of 0.20 is on the low side compared to the rest of the industry. XP is outperformed by 88.28% of its industry peers.
A Quick Ratio of 0.20 indicates that XP may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.20, XP is doing worse than 88.28% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.2
Quick Ratio 0.2
XP Yearly Current Assets VS Current LiabilitesXP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 8.65% over the past year.
XP shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 33.24% yearly.
The Revenue has been growing slightly by 6.74% in the past year.
XP shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 27.13% yearly.
EPS 1Y (TTM)8.65%
EPS 3Y7.19%
EPS 5Y33.24%
EPS Q2Q%20.59%
Revenue 1Y (TTM)6.74%
Revenue growth 3Y12.14%
Revenue growth 5Y27.13%
Sales Q2Q%5.6%

3.2 Future

The Earnings Per Share is expected to grow by 13.23% on average over the next years. This is quite good.
Based on estimates for the next years, XP will show a quite strong growth in Revenue. The Revenue will grow by 13.27% on average per year.
EPS Next Y13.69%
EPS Next 2Y13.51%
EPS Next 3Y13.23%
EPS Next 5YN/A
Revenue Next Year8.47%
Revenue Next 2Y10.7%
Revenue Next 3Y11.24%
Revenue Next 5Y13.27%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
XP Yearly Revenue VS EstimatesXP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5B 10B 15B 20B 25B
XP Yearly EPS VS EstimatesXP Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6 8 10

8

4. Valuation

4.1 Price/Earnings Ratio

XP is valuated reasonably with a Price/Earnings ratio of 10.60.
69.87% of the companies in the same industry are more expensive than XP, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of XP to the average of the S&P500 Index (26.84), we can say XP is valued rather cheaply.
XP is valuated reasonably with a Price/Forward Earnings ratio of 8.75.
84.10% of the companies in the same industry are more expensive than XP, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 22.48. XP is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 10.6
Fwd PE 8.75
XP Price Earnings VS Forward Price EarningsXP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, XP is valued cheaply inside the industry as 91.63% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, XP is valued cheaply inside the industry as 82.85% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 5.01
EV/EBITDA 7.81
XP Per share dataXP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as XP's earnings are expected to grow with 13.23% in the coming years.
PEG (NY)0.77
PEG (5Y)0.32
EPS Next 2Y13.51%
EPS Next 3Y13.23%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 16.02%, XP is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 7.91, XP pays a better dividend. On top of this XP pays more dividend than 92.05% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.32, XP pays a better dividend.
Industry RankSector Rank
Dividend Yield 16.02%

5.2 History

XP is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
XP Yearly Dividends per shareXP Yearly Dividends per shareYearly Dividends per share 2023 2024 0.5 1 1.5 2

5.3 Sustainability

41.40% of the earnings are spent on dividend by XP. This is a bit on the high side, but may be sustainable.
DP41.4%
EPS Next 2Y13.51%
EPS Next 3Y13.23%
XP Yearly Income VS Free CF VS DividendXP Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B
XP Dividend Payout.XP Dividend Payout, showing the Payout Ratio.XP Dividend Payout.PayoutRetained Earnings

XP INC - CLASS A

NASDAQ:XP (9/3/2025, 8:00:02 PM)

Premarket: 17.85 +0.04 (+0.22%)

17.81

-0.07 (-0.39%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)08-18 2025-08-18/amc
Earnings (Next)N/A N/A
Inst Owners85.5%
Inst Owner Change-2.89%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap9.40B
Analysts81.11
Price Target22.95 (28.86%)
Short Float %6.04%
Short Ratio4
Dividend
Industry RankSector Rank
Dividend Yield 16.02%
Yearly Dividend0.69
Dividend Growth(5Y)N/A
DP41.4%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.66%
Min EPS beat(2)1.46%
Max EPS beat(2)1.86%
EPS beat(4)2
Avg EPS beat(4)-0.19%
Min EPS beat(4)-2.46%
Max EPS beat(4)1.86%
EPS beat(8)6
Avg EPS beat(8)0.77%
EPS beat(12)9
Avg EPS beat(12)1.96%
EPS beat(16)13
Avg EPS beat(16)4.8%
Revenue beat(2)0
Avg Revenue beat(2)-5.2%
Min Revenue beat(2)-5.74%
Max Revenue beat(2)-4.66%
Revenue beat(4)0
Avg Revenue beat(4)-4.3%
Min Revenue beat(4)-5.74%
Max Revenue beat(4)-3.04%
Revenue beat(8)1
Avg Revenue beat(8)-2.41%
Revenue beat(12)2
Avg Revenue beat(12)-2.87%
Revenue beat(16)2
Avg Revenue beat(16)-3.8%
PT rev (1m)-0.88%
PT rev (3m)22.95%
EPS NQ rev (1m)3.27%
EPS NQ rev (3m)12.83%
EPS NY rev (1m)0.99%
EPS NY rev (3m)2.01%
Revenue NQ rev (1m)-0.43%
Revenue NQ rev (3m)-1.11%
Revenue NY rev (1m)-0.53%
Revenue NY rev (3m)-1.44%
Valuation
Industry RankSector Rank
PE 10.6
Fwd PE 8.75
P/S 2.92
P/FCF 5.01
P/OCF 4.82
P/B 2.3
P/tB 2.62
EV/EBITDA 7.81
EPS(TTM)1.68
EY9.43%
EPS(NY)2.04
Fwd EY11.43%
FCF(TTM)3.56
FCFY19.98%
OCF(TTM)3.69
OCFY20.73%
SpS6.1
BVpS7.73
TBVpS6.81
PEG (NY)0.77
PEG (5Y)0.32
Profitability
Industry RankSector Rank
ROA 1.32%
ROE 22.1%
ROCE 2.05%
ROIC 1.25%
ROICexc 1.29%
ROICexgc 1.75%
OM 33.11%
PM (TTM) 28.02%
GM N/A
FCFM 58.35%
ROA(3y)1.58%
ROA(5y)1.89%
ROE(3y)21.19%
ROE(5y)21.51%
ROIC(3y)1.49%
ROIC(5y)1.78%
ROICexc(3y)1.51%
ROICexc(5y)1.81%
ROICexgc(3y)1.95%
ROICexgc(5y)2.25%
ROCE(3y)2.48%
ROCE(5y)3.08%
ROICexcg growth 3Y-14.78%
ROICexcg growth 5Y-12.26%
ROICexc growth 3Y-16.98%
ROICexc growth 5Y-15.13%
OM growth 3Y0.94%
OM growth 5Y1.22%
PM growth 3Y-3.75%
PM growth 5Y4.69%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 4.06
Debt/FCF 9.13
Debt/EBITDA 14.85
Cap/Depr 137.12%
Cap/Sales 2.2%
Interest Coverage 16.42
Cash Conversion 174.43%
Profit Quality 208.2%
Current Ratio 0.2
Quick Ratio 0.2
Altman-Z 0.04
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)87.96%
Cap/Depr(5y)123.94%
Cap/Sales(3y)1.4%
Cap/Sales(5y)2.14%
Profit Quality(3y)163.55%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)8.65%
EPS 3Y7.19%
EPS 5Y33.24%
EPS Q2Q%20.59%
EPS Next Y13.69%
EPS Next 2Y13.51%
EPS Next 3Y13.23%
EPS Next 5YN/A
Revenue 1Y (TTM)6.74%
Revenue growth 3Y12.14%
Revenue growth 5Y27.13%
Sales Q2Q%5.6%
Revenue Next Year8.47%
Revenue Next 2Y10.7%
Revenue Next 3Y11.24%
Revenue Next 5Y13.27%
EBIT growth 1Y10.66%
EBIT growth 3Y13.19%
EBIT growth 5Y28.69%
EBIT Next Year14.55%
EBIT Next 3Y14.92%
EBIT Next 5Y18.63%
FCF growth 1Y60.25%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y62.72%
OCF growth 3YN/A
OCF growth 5YN/A